aromasil has been researched along with Bilateral Headache in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, R; Andou, J; Aoyama, H; Fujita, Y; Higashi, Y; Hirata, K; Kajiwara, T; Kanda, K; Kashiki, Y; Kimura, M; Kinoshita, H; Kitajima, M; Kobayashi, T; Kobayashi, Z; Koyama, H; Koyanagi, Y; Miura, S; Miyazaki, I; Monden, M; Morishita, Y; Nagao, K; Nomura, Y; Ogita, M; Oka, T; Satomi, S; Sonoo, H; Tabei, T; Takai, S; Takashima, S; Takatsuka, Y; Toge, T; Tominaga, K; Toyama, K; Watanabe, M; Watanabe, T; Yamaguchi, S; Yayoi, E; Yoshino, K | 1 |
de Belder, K; di Salle, E; Lanzalone, S; Lobelle, JP; Ornati, G; Paridaens, R; Polli, A; Thomas, J; Vermeiren, P; Wildiers, J; Zurlo, MG | 1 |
Buzdar, A; Howell, A | 1 |
Benedetti, MS; Coombes, RC; Di Salle, E; Evans, TR; Lassus, M; Ornati, G; Pianezzola, E | 1 |
1 review(s) available for aromasil and Bilateral Headache
Article | Year |
---|---|
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
3 trial(s) available for aromasil and Bilateral Headache
Article | Year |
---|---|
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer].
Topics: Administration, Oral; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Estrogens; Female; Headache; Hot Flashes; Humans; Middle Aged; Nausea; Postmenopause; Receptors, Estrogen | 2002 |
Safety, activity and estrogen inhibition by exemestane in postmenopausal women with advanced breast cancer: a phase I study.
Topics: Adult; Aged; Androstadienes; Antineoplastic Agents; Breast Neoplasms; Dizziness; Dose-Response Relationship, Drug; Estrogen Antagonists; Estrogens; Female; Headache; Humans; Middle Aged; Nausea; Postmenopause | 1998 |
Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.
Topics: Aged; Androstadienes; Androstenedione; Aromatase Inhibitors; Dehydroepiandrosterone; Estrogens; Female; Follicle Stimulating Hormone; Headache; Humans; Luteinizing Hormone; Menopause; Middle Aged; Testosterone | 1992 |